John Trainer's most recent trade in Neximmune Inc was a trade of 102,949 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 4, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neximmune Inc | John Trainer | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 102,949 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 89,222 | 89,222 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 89,100 | 89,100 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 78,100 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 50,440 | 50,440 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 28,987 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 27,660 | 27,660 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 18,720 | 18,720 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 13,727 | 13,727 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 10,267 | 10,267 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2022 | 125,200 | 186,969 | - | 0 | Common Stock | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 78,100 | 78,100 | - | - | Stock Option (Right to Buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2021 | 3,432 | 102,949 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Jul 2021 | 3,432 | 61,770 | - | 5.2 | 17,743 | Common Stock |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 3,432 | 106,381 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Jun 2021 | 3,432 | 58,338 | - | 5.2 | 17,743 | Common Stock |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Apr 2021 | 3,432 | 54,906 | - | 5.2 | 17,743 | Common Stock |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 3,432 | 109,813 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 3,432 | 113,245 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Apr 2021 | 3,432 | 51,474 | - | 5.2 | 17,743 | Common Stock |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 3,432 | 116,677 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 10 Mar 2021 | 3,432 | 48,042 | - | 5.2 | 17,743 | Common Stock |
| Neximmune Inc | John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 28,987 | 149,096 | - | - | Stock Option (right to buy) |